# Brian Taylor

> Brian Taylor is the chief executive officer of SmartLabs, where he applies more than two decades of biopharmaceutical manufacturing experience to an infrastructure problem: helping research teams access adaptable labs, technical operations, and scientific support without building every capability themselves. After roles at Genentech, GE Healthcare Life Sciences, and Zymergen, he joined SmartLabs in 2020, became interim CEO in early 2024, and now leads its expansion from managed research centers in the United States toward a globally deployable lab-as-a-service model.

- **Role:** Chief Executive Officer at SmartLabs
- **Organizations:** SmartLabs, Zymergen, GE Healthcare Life Sciences, Genentech
- **Education:** Bachelor's degree in Microbiology, University of Tennessee, Master's degree in International Policy Management, Kennesaw State University
- **Known for:** Developed turnkey manufacturing solutions for monoclonal antibody production using a single-use platform., Worked with the United States Congress on bringing generic-drug manufacturing back to the country., Launched and operated cGMP sites, including a facility in Spain.

## Career timeline

- **Early career** — Worked at Genentech on large-scale monoclonal antibody production processes.
- **Before 2018** — Led GE Healthcare Life Sciences' global Biomanufacturing Solutions business.
- **Before 2020** — Served as vice president of healthcare at Zymergen.
- **2020** — Joined SmartLabs as executive vice president of Biopharma Solutions.
- **2022** — Chaired a Meeting on the Mesa workshop on manufacturing needs for cell and gene therapeutics.
- **2024-01** — Assumed the role of interim CEO of SmartLabs, taking responsibility for day-to-day management and operational delivery.
- **2024-10** — Named a 2024 PharmaVoice 100 honoree in the Biotech Pathfinders category.
- **2025-06** — Led SmartLabs into a 10-year global partnership with International Workplace Group.
- **2025-08** — Announced a strategic partnership bringing Sonrai's AI data platform into SmartLabs research centers.
- **2026-05** — Announced SmartLabs' first international Custom Developed Solutions project at the ION life sciences precinct in Sydney.

## Achievements

- Developed turnkey manufacturing solutions for monoclonal antibody production using a single-use platform.
- Worked with the United States Congress on bringing generic-drug manufacturing back to the country.
- Launched and operated cGMP sites, including a facility in Spain.
- Built and led new service development at SmartLabs while overseeing technical operations, site operations, and commercial responsibilities.
- Selected as a 2024 PharmaVoice 100 Biotech Pathfinder.
- Led SmartLabs into a 10-year global partnership with IWG and its first international deployment in Sydney.

## Latest updates

- **2026-05** — SmartLabs announced its first international Custom Developed Solutions deployment at ION in Sydney, in partnership with Kurraba Group and IWG; delivery is targeted for the fourth quarter of 2028.
- **2025-08** — SmartLabs and Sonrai announced a global strategic partnership to bring AI-supported data management and analytics into SmartLabs research centers.
- **2025-06** — SmartLabs and IWG announced a 10-year partnership to deliver managed lab infrastructure internationally.
- **2024-10** — Taylor was selected for the 2024 PharmaVoice 100 in the Biotech Pathfinders category.

## Links

- Website: https://www.smartlabs.com/about-us/leadership/brian-taylor
- LinkedIn: https://www.linkedin.com/in/brian-taylor-5650a4112
- Twitter/X: https://twitter.com/JoinSmartLabs
- Facebook: https://www.facebook.com/joinsmartlabs

---

Profile page: https://yespress.io/brian-taylor
Published by YesPress — https://yespress.io
Last updated: 2026-08-18